{"name":"Novexel Inc","slug":"novexel-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPdkdOSjAyN1BXME5ROHYzcWJHSUZkX044anhKeG9HUDd1c1Ewc2RoNERzalI3QkplOE5QYmZBZHpRQnRzeS1CajZSTGlsWF8wMGYyUHJPbjk5YXRWWU96ZEdmQmhmYjdYYzlTeDFGQm9RQzF3b1p4eUpER0d5SFVkclNxR0tJY1lNUjFBN0E4djZYWWtkTVhVclZCUHU2V256aTNr?oc=5","date":"2016-07-27","type":"pipeline","source":"Business Valuation Resources","summary":"Royalty Rates in Biotech: BVR's Guide to Full-Text Licensing Agreements - Business Valuation Resources","headline":"Royalty Rates in Biotech: BVR's Guide to Full-Text Licensing Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxPNWVINC1uYmVhdEgyOVlrNGRfWnNfOFZpVjh1Q3R2Vm5CMDlPemRRQzgtdnhPR01EOXJQNklrN1ZjQjAySTRxT2JIS21pUHloMFRiNFhESXdBaHhSa2hhcDVTbFR6YVlGc1E4QU81c1FuYnBmSnFzRUFraVlDekRqMXJMTEtITXVWMjhBSEV1RVU1Tk40UDNkSjhsRXRIQTFzSnNjeDJNQkotOWVCeVkwUEFWSTc0RU1tTDltbzNvd0YzTmExNmdaSnVCdjIwRXB5azdyNGpmRWtnSzFxQUxqSGtOUk03VzNZTFl3VEtXeU9TVkM2NkdFRkVqNmVLbUM1OFJJOFJIUkRpU0dmSHprQ3RqQXBtbWZVSHh1Nm5aNnJLTWg5T01jeEZoZ3prSHpCMjBIVlVKZ2JIYXNKY0pfMElXNUo0NC1tdEE?oc=5","date":"2011-10-18","type":"trial","source":"AstraZeneca","summary":"AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections - AstraZeneca","headline":"AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNUmF1b0ZRRWtrcTlxaGFpYk5tUGdnNnp6MWFmdnBXZmlQYnh3bmhGdjNMTG1iblpXNlB1TTRlV1laTXFtS19jWnhxQkNvaEtCV0VnbU5jb0Jic2xXQk81Q2E4X3RyQ0VaVlBicWMyTEFWbk1sNHVuNUpYTEw1b2dLRFNaT0NQemJaQkl2OGZ1dmhlODZfZmRNMm5JNWlXaTZTemRkb045aEJiVFJrT2pCSDNRcnNBU0tFSDVROE9ScVM2ZURic1dsQk1rVmk?oc=5","date":"2009-12-23","type":"deal","source":"AstraZeneca","summary":"AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories - AstraZeneca","headline":"AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}